NR1D1 :: MAML1 epithelioid and spindle cell sarcoma mimicking pseudomyogenic hemangioendothelioma in core biopsy: A case report and review of the literature
Genes, Chromosomes and Cancer · 2023
DOI: 10.1002/gcc.23186 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2023. Verfasst von Laura M Warmke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Hemangioendothelioma, Hemangioma, Sarcoma, Hemangioendothelioma, Epithelioid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epithelioid and spindle cell sarcomas with NR1D1 :: MAML1/2 gene fusions are rare and emerging entities. Only six cases of NR1D1 ‐rearranged mesenchymal tumors have previously been reported in the literature; they are often characterized by an epithelioid morphology, at least focal pseudogland formation, prominent cytoplasmic vacuoles, and focal to diffuse immunohistochemical expression of keratin. We herein report the first case of an NR1D1 :: MAML1 epithelioid and spindle cell sarcoma with dual immunohistochemical expression of ERG and FOSB, mimicking a pseudomyogenic hemangioendothelioma (PHE) on core biopsy. The sarcoma arose in the left forearm of a 64‐year‐old man. Initial biopsy showed a mesenchymal neoplasm composed of epithelioid and spindle cells dispersed in myxoid stroma with scattered stromal neutrophils. The morphologic features, combined with the dual immunohistochemical expression of ERG and FOSB, initially mimicked PHE, representing an important potential diagnostic pitfall. The patient subsequently underwent a radical resection, which showed a much more diffuse epithelioid appearance with nested architecture and pseudogland formation. Next‐generation sequencing was performed on the resection specimen, which revealed an NR1D1 :: MAML1 gene fusion, confirming the final diagnosis. Given the fully malignant potential of this tumor, knowledge and recognition of this rare entity are essential to ensure proper management, prevent misdiagnosis, and further characterize the clinical course of this emerging entity. Comprehensive molecular testing can help to identify these rare tumors and exclude the possibility of epithelioid mimics, including PHE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Orthopedic Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Laura M Warmke, Jessica L Davis
Zitieren
APA
Warmke, L. M., Collier, C. D., & Davis, J. L. (2023). NR1D1 :: MAML1 epithelioid and spindle cell sarcoma mimicking pseudomyogenic hemangioendothelioma in core biopsy: A case report and review of the literature. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23186
Vancouver
Warmke LM, Collier CD, Davis JL. NR1D1 :: MAML1 epithelioid and spindle cell sarcoma mimicking pseudomyogenic hemangioendothelioma in core biopsy: A case report and review of the literature. Genes, Chromosomes and Cancer. 2023. doi:10.1002/gcc.23186
BibTeX
@article{Warmke2023,
author = {Warmke, Laura M and Collier, Christopher D and Davis, Jessica L},
title = {NR1D1 :: MAML1 epithelioid and spindle cell sarcoma mimicking pseudomyogenic hemangioendothelioma in core biopsy: A case report and review of the literature},
journal = {Genes, Chromosomes and Cancer},
year = {2023},
doi = {10.1002/gcc.23186}
}
EUVIMED